PPIDT00438
Drug Information
| Name | Valoctocogene roxaparvovec |
|---|---|
| Sequence | Not Available |
| DrugBank_ID | DB15561 |
| Type | biotech |
| Indication | Valoctocogene roxaparvovec is indicated for the treatment of severe hemophilia A (congenital factor VIII deficiency) in adult patients without a history of factor VIII inhibitors and without detectable antibodies to adeno-associated virus serotype 5 (AAV5).[L43282] |
Dosage Forms
| Form | Route | Strength |
|---|---|---|
| Injection, solution | Intravenous |
20000000000000 vg/ml
|
| Injection, solution | Intravenous |
20000000000000 {GC}/1mL
|
Target Information
| Role | Uniprot_ID | Gene_Name | Entity_Name | Organism | Actions | Internal link |
|---|---|---|---|---|---|---|
| No target records. | ||||||